The Liver Health Study for Patients with NAFLD

NACompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

August 9, 2017

Primary Completion Date

March 3, 2022

Study Completion Date

April 29, 2023

Conditions
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisObesity
Interventions
BEHAVIORAL

Phase II: Lifestyle treatment

Subjects will undergo energy restriction and exercise training over a 9 month period.

BEHAVIORAL

Phase II: Control treatment

Subjects will receive dietary advice and receive information on a stretching program.

OTHER

Phase I: Observational studies

The liver samples from patients undergoing bariatric surgery or a diagnostic liver biopsy will undergo in vitro assays to determine the capacity of the tissue to burn fat

Trial Locations (1)

65212

University of Missouri, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT03151798 - The Liver Health Study for Patients with NAFLD | Biotech Hunter | Biotech Hunter